SEC 10-K / 10-Q · Updated Daily

NNVC

— NANOVIRICIDES, INC. Financials

Standardized 10-K and 10-Q line items with working capital, liquidity, solvency, profitability, efficiency, and cash-flow ratios — each chartable over any trailing window of filings, with every number confirmable against the original SEC document.

Financials Ownership

Latest Filing Snapshot — 10-Q for period ended 2026-03-31

Metric	Value	What it means
Current Ratio	3.17	Current assets ÷ current liabilities. Above 1 means short-term assets cover short-term obligations.
Debt-to-Equity	0.12	Total liabilities ÷ stockholders' equity — how much of the company is financed by debt vs. equity.
Net Margin	—	Net income ÷ revenue.
Return on Equity	-21.73%	Net income ÷ stockholders' equity.

Raw Line Items

Liquidity

Solvency & Leverage

Profitability

Efficiency

Cash Flow

Current Ratio

Not enough filings with this line item yet.

All Filings

Form	Fiscal Period	Period End	Filed
10-Q	—	2026-03-31	2026-05-15
10-Q	—	2025-12-31	2026-02-17
10-Q	—	2025-09-30	2025-11-14
10-K	—	2025-06-30	2025-09-29
10-Q	—	2025-03-31	2025-05-15
10-Q	—	2024-12-31	2025-02-14
10-Q	—	2024-09-30	2024-11-14
10-K	—	2024-06-30	2024-09-27
10-Q	—	2024-03-31	2024-05-15
10-Q	—	2023-12-31	2024-02-14
10-Q	—	2023-09-30	2023-11-14
10-K	—	2023-06-30	2023-10-13
10-Q	—	2023-03-31	2023-05-15
10-Q	—	2022-12-31	2023-02-14
10-Q	—	2022-09-30	2022-11-14
10-K	—	2022-06-30	2022-10-13
10-Q	—	2022-03-31	2022-05-16
10-Q	—	2021-12-31	2022-02-14
10-Q	—	2021-09-30	2021-11-15
10-K	—	2021-06-30	2021-10-12
10-Q	—	2021-03-31	2021-05-14
10-Q	—	2020-12-31	2021-02-16
10-Q	—	2020-09-30	2020-11-16
10-K	—	2020-06-30	2020-10-13
10-Q	—	2020-03-31	2020-06-22
10-Q	—	2019-12-31	2020-02-14
10-Q	—	2019-09-30	2019-11-15
10-K	—	2019-06-30	2019-08-23
10-Q	—	2019-03-31	2019-05-15
10-Q	—	2018-12-31	2019-02-14
10-Q	—	2018-09-30	2018-11-14
10-K	—	2018-06-30	2018-10-12
10-Q	—	2018-03-31	2018-05-21
10-Q	—	2017-12-31	2018-02-20
10-Q	—	2017-09-30	2017-11-14
10-K	—	2017-06-30	2017-09-28
10-Q	—	2017-03-31	2017-05-15
10-Q	—	2016-12-31	2017-02-14
10-Q	—	2016-09-30	2016-11-14
10-K	—	2016-06-30	2016-09-16
10-Q	—	2016-03-31	2016-05-10
10-Q	—	2015-12-31	2016-02-09
10-Q	—	2015-09-30	2015-11-09
10-K	—	2015-06-30	2015-09-14
10-Q	—	2015-03-31	2015-05-15
10-Q/A	—	2014-12-31	2015-02-25
10-Q	—	2014-12-31	2015-02-24
10-Q	—	2014-09-30	2014-11-14
10-Q/A	—	2014-09-30	2015-02-23
10-K/A	—	2014-06-30	2014-09-30
10-K	—	2014-06-30	2014-09-29
10-K/A	—	2014-06-30	2015-02-23
10-Q	—	2014-03-31	2014-05-15
10-Q	—	2013-12-31	2014-02-14
10-Q/A	—	2013-09-30	2013-11-18
10-Q	—	2013-09-30	2013-11-14
10-K/A	—	2013-06-30	2013-10-08
10-K	—	2013-06-30	2013-09-30
10-Q/A	—	2013-03-31	2013-05-20
10-Q	—	2013-03-31	2013-05-15
10-Q/A	—	2012-12-31	2013-02-22
10-Q	—	2012-12-31	2013-02-14
10-Q	—	2012-09-30	2012-11-19
10-K/A	—	2012-06-30	2012-10-26
10-K	—	2012-06-30	2012-10-15
10-Q	—	2012-03-31	2012-05-21
10-Q/A	—	2011-12-31	2012-06-14
10-Q	—	2011-12-31	2012-02-14
10-Q	—	2011-09-30	2011-11-14
10-Q/A	—	2011-09-30	2012-06-14
10-Q/A	—	2011-09-30	2011-12-12
10-K/A	—	2011-06-30	2011-10-20
10-K/A	—	2011-06-30	2012-06-14
10-K	—	2011-06-30	2011-10-13
10-Q	—	2011-03-31	2011-05-20
10-Q	—	2010-12-31	2011-02-18
10-Q	—	2010-09-30	2010-11-19
10-K	—	2010-06-30	2010-10-13
10-Q	—	2010-03-31	2010-05-20
10-Q	—	2009-12-31	2010-02-22
10-Q/A	—	2009-12-31	2010-03-18
10-Q	—	2009-09-30	2009-11-23
10-K/A	—	2009-06-30	2010-04-16
10-K/A	—	2009-06-30	2010-03-22
10-K	—	2009-06-30	2009-10-13
10-Q	—	2009-03-31	2009-05-15
10-Q	—	2008-12-31	2009-02-20
10-Q	—	2008-09-30	2008-11-19
10-K	—	2008-06-30	2008-10-29
10-Q	—	2008-03-31	2008-05-20

Source: SEC EDGAR 10-K/10-Q XBRL data. For informational purposes only — not investment advice.